Authors: Yuen, AR Sikic, BI

Citation: Ar. Yuen et Bi. Sikic, Clinical studies of antisense therapy in cancer, FRONT BIOSC, 5, 2000, pp. D588-D593

Authors: Yuen, AR Fuks, JZ Ettinger, DS Chang, AY Ruckdeschel, JC Phan, SC Blum, RH

Citation: Ar. Yuen et al., Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: An Eastern Cooperative Oncology Group Study (PA586), CA J SCI AM, 6(1), 2000, pp. 34-39

Authors: Yuen, AR Zou, GY Turrisi, AT Sause, W Komaki, R Wagner, H Aisner, SC Livingston, RB Blum, R Johnson, DH

Citation: Ar. Yuen et al., Similar outcome of elderly patients in intergroup trial 0096 - Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma, CANCER, 89(9), 2000, pp. 1953-1960

Authors: Yuen, AR Halsey, J Fisher, GA Holmlund, JT Geary, RS Kwoh, TJ Dorr, A Sikic, BI

Citation: Ar. Yuen et al., Phase I study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer, CLIN CANC R, 5(11), 1999, pp. 3357-3363

Authors: Yuen, AR

Citation: Ar. Yuen, Progress in the non-Hodgkin's lymphomas, ANN ONCOL, 10, 1999, pp. 19-22